AnalystsJonathan WollebenJonathan Wolleben's Stock Forecasts
AnalystsJonathan Wolleben
Sectors:
Industries:
Analyst Ranking
Top 9%
#417 out of 4699 analysts
Average Return
+8.79%
Win Rate
47%74 out of 158
Risk vs Reward
Poor
Good
Jonathan Wolleben's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Madrigal Pharmaceuticals IncMDGL | +365.01% | $64.44 | $299.65 | 2022-05-10 - 2023-05-09 | Buy |
Pharvaris NvPHVS | +206.28% | $8.12 | $24.87 | 2023-02-27 - 2024-02-26 | Buy |
Pharvaris NvPHVS | +198.29% | $8.75 | $26.10 | 2023-01-11 - 2024-01-10 | Buy |
Pharvaris NvPHVS | +194.90% | $8.62 | $25.42 | 2022-12-09 - 2023-12-08 | Buy |
Proqr Therapeutics NvPRQR | +188.44% | $0.79 | $2.27 | 2022-04-14 - 2023-04-13 | Buy |
Jonathan Wolleben Analyst Color
Get additional color on Jonathan Wolleben's coverage of popular stocks
Jonathan Wolleben's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Savara IncSVRA | 7 | Buy | $9.00 | +140.64% | Reiterates | 7 days ago |
Crinetics Pharmaceuticals IncCRNX | 12 | Buy | $80.00 | +54.56% | Reiterates | 11 days ago |
Allakos IncALLK | 6 | Buy | $3.00 | +329.18% | Reiterates | 12 days ago |
Dbv Technologies SaDBVT | 10 | Buy | $5.00 | +635.29% | Reiterates | 14 days ago |
Rhythm Pharmaceuticals IncRYTM | 1 | Buy | $64.00 | +35.59% | Initiates Coverage On | 21 days ago |
Aura Biosciences IncAURA | 6 | Buy | $23.00 | +172.84% | Maintains | 25 days ago |
Skye Bioscience IncSKYE | 1 | Buy | $15.00 | +290.63% | Initiates Coverage On | a month ago |
Sagimet Biosciences IncSGMT | 8 | Buy | $32.00 | +669.23% | Maintains | 2 months ago |
Structure Therapeutics IncGPCR | 6 | Buy | $86.00 | +112.98% | Maintains | 2 months ago |
Protagonist Therapeutics IncPTGX | 9 | Buy | $43.00 | -1.83% | Maintains | 2 months ago |
Biocryst Pharmaceuticals IncBCRX | 4 | Buy | $16.00 | +115.05% | Maintains | 2 months ago |
Madrigal Pharmaceuticals IncMDGL | 8 | Buy | $385.00 | +79.21% | Maintains | 3 months ago |
Mirum Pharmaceuticals IncMIRM | 8 | Buy | $68.00 | +75.48% | Maintains | 4 months ago |
Larimar Therapeutics IncLRMR | 11 | Buy | $25.00 | +285.80% | Reiterates | 4 months ago |
Altimmune IncALT | 9 | Buy | $24.00 | +293.44% | Maintains | 5 months ago |
Ocular Therapeutix IncOCUL | 14 | Buy | $22.00 | +132.07% | Maintains | 5 months ago |
Rallybio CorpRLYB | 11 | Buy | $8.00 | +607.96% | Reiterates | 6 months ago |
Pharvaris NvPHVS | 9 | Buy | $50.00 | +175.18% | Maintains | 6 months ago |
Spruce Biosciences IncSPRB | 6 | Buy | $3.00 | +565.19% | Maintains | 7 months ago |
Clearside Biomedical IncCLSD | 8 | Buy | $5.00 | +216.46% | Reiterates | 7 months ago |
Proqr Therapeutics NvPRQR | 4 | Buy | $6.00 | N/A | Reiterates | a year ago |
Warner Music Group CorpWMG | 1 | Buy | $24.00 | N/A | Maintains | a year ago |
Strongbridge Biopharma PLCSBBP | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.